Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance

Several clinical trials started during the COVID-19 pandemic to discover effective therapeutics led to identify a few candidates from the major clinical trials. However, in the past several months, quite a few SARS-CoV-2 variants have emerged with significant mutations. Major mutations in the S-glyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Chiranjib, Bhattacharya, Manojit, Sharma, Ashish Ranjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606259/
https://www.ncbi.nlm.nih.gov/pubmed/34920267
http://dx.doi.org/10.1016/j.coph.2021.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606259/
https://www.ncbi.nlm.nih.gov/pubmed/34920267
http://dx.doi.org/10.1016/j.coph.2021.11.006

Ejemplares similares